Pharmacogenetics - where are we and where are we heading?

被引:1
作者
Kola, I [1 ]
机构
[1] Merck & Co Inc, Basic Res, Rahway, NJ 07065 USA
关键词
D O I
10.2217/14622416.6.8.793
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:793 / 795
页数:3
相关论文
共 7 条
[1]  
BERENSON A, 2005, NY TIMES 0712
[2]  
GOLDSTEIN D, 2005, OECD C PHARM DRUG RE
[3]   Can the pharmaceutical industry reduce attrition rates? [J].
Kola, I ;
Landis, J .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) :711-715
[4]  
KOLA I, 2005, CURR OPIN BIOTECHNOL
[5]   Laying the foundations for personalized medicines [J].
Marshall, A .
NATURE BIOTECHNOLOGY, 1997, 15 (10) :954-957
[6]  
SHAH R, 2005, OECD C PHARM DRUG RE
[7]   Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase [J].
Weinshilboum, RM ;
Otterness, DM ;
Szumlanski, CL .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :19-52